Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian approaches in modern drug development, emphasizing their potential to improve ...
Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
I like Bayesian statistics but I hate the way they are being forced upon us as the only way of knowing God. And I think frequentist statistics have much to recommend themselves, even when embedded in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results